SCHEMBL7488352

SCHEMBL7488352

CCCNC(=O)c1cnc(Cl)c(Cl)c1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.54
KMT2A Q03164 5/20 0.53
OPRM1 P35372 1/20 0.53
OPRD1 P41143 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
POLB P06746 1/20 0.51
THRB P10828 1/20 0.51
RECQL P46063 1/20 0.51
CNR1 P21554 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
KDM4E B2RXH2 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HDAC3 O15379 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11147008 0.88 CNR1 (0.60) ALDH1A1KMT2AOPRM1OPRD1L3MBTL1
SCHEMBL2960085 0.87 ALDH1A1 (0.57) ALDH1A1KMT2AOPRM1OPRD1L3MBTL1
SCHEMBL2088176 0.84 KMT2A (0.56) ALDH1A1KMT2AOPRM1OPRD1HSD17B10
SCHEMBL3924702 0.82 ALDH1A1 (0.52) ALDH1A1KMT2AOPRM1OPRD1L3MBTL1
SCHEMBL3927688 0.80 KMT2A (0.58) ALDH1A1KMT2AOPRM1OPRD1TDP1
SCHEMBL13977996 0.78 ALDH1A1 (0.54) ALDH1A1KMT2AOPRM1OPRD1L3MBTL1
SCHEMBL11148885 0.78 KMT2A (0.56) ALDH1A1KMT2AOPRM1OPRD1TDP1
SCHEMBL9592081 0.78 POLB (0.55) ALDH1A1KMT2AL3MBTL1TDP1POLB
SCHEMBL13018868 0.77 POLB (0.53) ALDH1A1KMT2AL3MBTL1TDP1POLB
SCHEMBL16000808 0.76 KMT2A (0.54) ALDH1A1KMT2AOPRM1OPRD1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242396-A1 NEW P2X 7 RECEPTOR ANTAGONISTS FOR USE IN THE TREATMENT OF INFLAMMATORY, IMMUNE OR CARDIOVASCULAR DISEASES AstraZeneca AB (SE) 2002-09-25 EP disclosed
WO-2001044213-A1 NEW P2X7 RECEPTOR ANTAGONISTS FOR USE IN THE TREATMENT OF INFLAMMATORY, IMMUNE OR CARDIOVASCULAR DISEASES ASTRAZENECA AB (SE) 2001-06-21 WO disclosed